← All trials
NCT01510912
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2012
- Primary completion
- Mar 1, 2013
- Completion date
- Mar 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 602
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- IrokoLead sponsor
- Quest Research InstituteOverall official - principal investigator
- Clinical Investigation Specialists, IncOverall official - principal investigator
- Office of Matthew Barton, MDOverall official - principal investigator
- Peters Medical ResearchOverall official - principal investigator
- Clinical Investigations of Texas, LLCOverall official - principal investigator
- Charlottesville Medical Research Center, LLCOverall official - principal investigator
- Hypothetest, LLCOverall official - principal investigator
- Heartland Research Associates, LLCOverall official - principal investigator
- Alliance Clinical ResearchOverall official - principal investigator
- Quality Research IncOverall official - principal investigator
- Triad Clinical ResearchOverall official - principal investigator
- Altoona Center for Clinical ResearchOverall official - principal investigator
- Acri-Phase I, LLCOverall official - principal investigator
- Professional Research Network of Kansas, LLCOverall official - principal investigator
- Progressive Clinical ResearchOverall official - principal investigator
- Drug Trials AmericaOverall official - principal investigator
- Sterling Research Group, LtdOverall official - principal investigator
- Peninsula Research, IncOverall official - principal investigator
- Westside Center for Clinical ResearchOverall official - principal investigator
- Expresscare Clinical ResearchOverall official - principal investigator
- Clinical Trials Technology IncOverall official - principal investigator
- Clinical Study Center of Asheville, LLCOverall official - principal investigator
- Sundance Clinical Research, LLCOverall official - principal investigator
- Lynn Institute of the OzarksOverall official - principal investigator
- Drug Studies AmericaOverall official - principal investigator
- Premier Research GroupOverall official - principal investigator
- Jacksonville Center for Clinical ResearchOverall official - principal investigator
- Pinnacle Research GroupOverall official - principal investigator
- Meridien ResearchOverall official - principal investigator
- Well Pharma Medical Research CorporationOverall official - principal investigator
- Radiant ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.